NCT02245061

Brief Summary

The identification of the epileptogenic zone (EZ) during pharmacoresistant focal epilepsy presurgical assessment frequently requires intracranial recordings like stereo-electroencephalography (SEEG). Cortical direct electrical stimulation (DES) is commonly used during SEEG for functional mapping or to induce seizure. However, the recording of seizures is sometimes insufficient to circumscribe the EZ and development of new biomarkers is necessary. The cortex within the EZ is thought to be hyperexcitable. The "paired pulses" paradigm, using transcranial magnetic stimulation (TMS), allows determining the hemispheric cortical excitability level. The investigators hypothesize that paired pulses DES during SEEG could provide useful information for EZ identification.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2014

Completed
Same day until next milestone

Study Start

First participant enrolled

September 9, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2014

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

October 23, 2019

Status Verified

October 1, 2019

Enrollment Period

7.1 years

First QC Date

September 9, 2014

Last Update Submit

October 22, 2019

Conditions

Keywords

pharmacoresistant focal epilepsycortical excitabilitypaired pulsesTMSSEEGDES

Outcome Measures

Primary Outcomes (1)

  • Presence of a significant difference between the evoked responses to paired pulses cortical electrical stimulation of epileptogenic zone cortex and of normal cortex

    Low frequency single pulse electrical stimulation induces several cortico-cortical electroencephalographic responses: early-physiological and/or late-pathological. We expect different paired pulses modulation of those responses according the excitability level of the stimulated cortex (in terms of latency, amplitude, surface, frequency power)

    between Day 7 and 21 (End of the stereoelectroencephalographic recordings)

Secondary Outcomes (2)

  • Presence of a difference of responses patterns between anatomic regions and/or lesion type

    between Day 7 and 21 (End of the stereoelectroencephalographic recordings )

  • Presence of a difference between transcranial magnetic paired pulses stimulations and intracranial paired pulses cortical direct electrical stimulations

    Between Day 7 and 21 (End of the stereoelectroencephalographic recordings)

Study Arms (1)

paired pulses cortical electrical stimulation

EXPERIMENTAL
Other: paired pulses cortical electrical stimulation

Interventions

paired pulses cortical electrical stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age above 18 years old
  • Pharmacoresistant focal epilepsy patients undergoing a stereo-electroencephalographic recording
  • Provide written consent to the study after receiving clear information
  • Be a beneficiary or member of health insurance plan

You may not qualify if:

  • Patient with contraindication for MRI scanning
  • Pregnancy
  • Prohibition on participation in other research, apart from any other non-interventional research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital neurologique de Lyon

Lyon, 69003, France

RECRUITING

MeSH Terms

Conditions

Epilepsies, Partial

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2014

First Posted

September 19, 2014

Study Start

September 9, 2014

Primary Completion

September 30, 2021

Study Completion

September 30, 2021

Last Updated

October 23, 2019

Record last verified: 2019-10

Locations